BioCentury | Aug 6, 2007
Company News

Valentis genitourinary, cardiovascular news

The company changed its name to Urigen Pharmaceuticals Inc. and its ticker to URGP. VLTS reverse-merged with Urigen N.A. Inc. last month (see BioCentury, July 23). Valentis Inc. (VLTS), Burlingame, Calif. Business: Genitourinary, Cardiovascular WIR...
BioCentury | Jul 23, 2007
Company News

Urigen N.A. Inc., Valentis deal

The companies completed their previously announced reverse-merger and will form Urigen Pharmaceuticals Inc. (see BioCentury, Oct. 9, 2006). Valentis' ticker will remain VLTS until its name change is complete. Urigen N.A. Inc. , Burlingame, Calif. Valentis...
BioCentury | Jun 25, 2007
Company News

Urigen N.A. Inc. board of directors update

Urigen N.A. Inc. , Burlingame, Calif. Business: Genitourinary Resigned: Benson Fong WIR Staff Genitourinary...
BioCentury | Jan 15, 2007
Company News

Urigen N.A. Inc. management update

Urigen N.A. Inc. , Burlingame, Calif. Business: Genitourinary Hired: Dennis Giesing as director of product development, formerly CEO of CepheidRx LLC WIR Staff...
BioCentury | Dec 4, 2006
Company News

Urigen N.A. Inc. management update

Urigen N.A. Inc. , Burlingame, Calif. Business: Genitourinary Promoted: Terry Nida to COO from VP of worldwide sales, marketing and corporate development; he replaces Michael Flashner, who departe WIR Staff...
BioCentury | Nov 6, 2006
Clinical News

U101: Phase IIb data

...to patient selection in subsequent trials. Urigen is merging with Valentis Inc. (VLTS, Burlingame, Calif.). Urigen NA Inc....
Items per page:
1 - 6 of 6
BioCentury | Aug 6, 2007
Company News

Valentis genitourinary, cardiovascular news

The company changed its name to Urigen Pharmaceuticals Inc. and its ticker to URGP. VLTS reverse-merged with Urigen N.A. Inc. last month (see BioCentury, July 23). Valentis Inc. (VLTS), Burlingame, Calif. Business: Genitourinary, Cardiovascular WIR...
BioCentury | Jul 23, 2007
Company News

Urigen N.A. Inc., Valentis deal

The companies completed their previously announced reverse-merger and will form Urigen Pharmaceuticals Inc. (see BioCentury, Oct. 9, 2006). Valentis' ticker will remain VLTS until its name change is complete. Urigen N.A. Inc. , Burlingame, Calif. Valentis...
BioCentury | Jun 25, 2007
Company News

Urigen N.A. Inc. board of directors update

Urigen N.A. Inc. , Burlingame, Calif. Business: Genitourinary Resigned: Benson Fong WIR Staff Genitourinary...
BioCentury | Jan 15, 2007
Company News

Urigen N.A. Inc. management update

Urigen N.A. Inc. , Burlingame, Calif. Business: Genitourinary Hired: Dennis Giesing as director of product development, formerly CEO of CepheidRx LLC WIR Staff...
BioCentury | Dec 4, 2006
Company News

Urigen N.A. Inc. management update

Urigen N.A. Inc. , Burlingame, Calif. Business: Genitourinary Promoted: Terry Nida to COO from VP of worldwide sales, marketing and corporate development; he replaces Michael Flashner, who departe WIR Staff...
BioCentury | Nov 6, 2006
Clinical News

U101: Phase IIb data

...to patient selection in subsequent trials. Urigen is merging with Valentis Inc. (VLTS, Burlingame, Calif.). Urigen NA Inc....
Items per page:
1 - 6 of 6